Neurology 1308 - Neurology Alert - Aug 01, 2009

Target Audience:

This activity is intended for the neurologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Physician Editor
Matthew Fink, MD
Vice Chairman, Professor of Clinical Neurology
Weill Medical College
Chief of Division of Stroke and Critical Care Neurology
NewYork Presbyterian Hospital

Peer Reviewer
M. Flint Beal, MD
Professor and Chairman,
Department of Neurology and Neuroscience

Assistant Editors
Susan Gauthier, DO, MS
Assistant Professor of Neurology and Neuroscience
Weill Cornell Medical College

John J. Caronna, MD
Professor of Clinical Neurology;
Specialty area, Stroke and General Neurology

Michael Rubin, MD

Professor of Clinical Neurology
Weill Cornell Medical College

Dara Jamieson, MD
Associate Professor of Clinical Neurology
Weill Cornell Medical College

Authors
Russell L. Chin, MD
Assistant Professor of Neurology and Neuroscience
Weill Cornell Medical College

Panida Piboolnurak, MD

Assistant Professor
Department of Neurology and Neuroscience
Weill Medical College
Cornell University

Subjects:

  • Interferon beta and Glatiramer Acetate: Equivalent for the Treatment of MS?
  • Erythromelalgia: Clinical Features, Effective Treatment with Carbamazepine
  • Why Is a Woman Different from a Man, at Least as Far as Stroke Risk?
  • Sensory Neuronopathy: Diagnostic Criteria
  • 'Hardening of the Arteries' in the Central Nervous System in Scleroderma
  • Autonomic Nervous System Dysfunction in PD with and without Dementia, and in Dementia with Lewy Bodies

Objectives:

  • Present current scientific data regarding diagnosis and treatment of neurologic disease, including stroke, Alzheimer?s disease, transient ischemic attack, and coma
  • Discuss the pathogenesis and treatment of pain
  • Present basic science lessons in brain function
  • Discuss information regarding new drugs for commonly diagnosed diseases and new uses for traditional drugs
  • Discuss nonclinical issues of importance to neurologists, such as the right to die and the physician?s legal obligation to patients with terminal illness

Financial Disclosure:

Neurology Alert's physician editor, Matthew Fink, MD, reports no consultant, stockholder, speaker's bureau, research, or other relationships related to this field of study. Assistant editors Susan Gauthier, DO, MS, and John J. Caronna, MD, authors Russell L. Chin, MD, and Panida Piboolnurak, MD, and peer reviewer M. Flint Beal, MD, report no consultant, stockholder, speaker's bureau, research, or other financial relationship with any company having ties to this field of study. Assistant editor Dara Jamieson, MD reports she is a retained consultant for Boehringer Ingelheim, Merck, and Ortho-McNeil, and is on the speaker's bureau for Boehringer Ingelheim and Merck. Assistant editor Michael Rubin, MD, FRCP(C) reports that he receives grant/research support from Pfizer and is on the speaker's bureau of Athena Diagnostics.

Copyright 2009 AHC Media. All rights reserved.